Chris Mansi, MD is CEO and Co-Founder of Viz.ai, the leader in AI-powered disease detection and care coordination. Dr. Mansi co-founded Viz.ai in 2016 with a mission of using artificial intelligence to increase access to life-saving treatments. Under his leadership, Viz.ai has achieved industry milestones, including two de novo approvals by the FDA for AI computer aided triage in 2018 and cardiovascular machine learning-based notification software in 2023. Viz.ai was also the first to be granted CMS New Technology Add-on Payment (NTAP) for AI in 2020. Today, the Viz.ai One Platform has 30 care pathways, is adopted in more than 1,400 hospitals and collaborates with 7 of the leading, global pharmaceutical and medical device companies, improving access to life saving treatments for more than 230M people.
